orabase and Myelodysplastic-Syndromes

orabase has been researched along with Myelodysplastic-Syndromes* in 1 studies

Trials

1 trial(s) available for orabase and Myelodysplastic-Syndromes

Article	Year
NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 03-01, Volume: 24, Issue:5 Topics: Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Cancer Vaccines; Carboxymethylcellulose Sodium; Combined Modality Therapy; Decitabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Humans; Immunotherapy; Interferon Inducers; Leukemia, Myeloid, Acute; Membrane Proteins; Middle Aged; Myelodysplastic Syndromes; Myeloid Cells; Poly I-C; Polylysine; T-Lymphocytes, Cytotoxic; Treatment Outcome	2018

Article

Year

NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2018, 03-01, Volume: 24, Issue:5

Topics: Aged; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Cancer Vaccines; Carboxymethylcellulose Sodium; Combined Modality Therapy; Decitabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Feasibility Studies; Humans; Immunotherapy; Interferon Inducers; Leukemia, Myeloid, Acute; Membrane Proteins; Middle Aged; Myelodysplastic Syndromes; Myeloid Cells; Poly I-C; Polylysine; T-Lymphocytes, Cytotoxic; Treatment Outcome

2018